Medicina
Département
Hebrew University of Jerusalem
Jerusalén, IsraelPublications en collaboration avec des chercheurs de Hebrew University of Jerusalem (6)
2023
-
Evaluation of European-based polygenic risk score for breast cancer in Ashkenazi Jewish women in Israel
Journal of Medical Genetics, Vol. 60, Núm. 12, pp. 1186-1197
2021
-
Motixafortide and pembrolizumab combined to nanoliposomal irinotecan, fluorouracil, and folinic acid in metastatic pancreatic cancer: The COMBAT/ KEYNOTE-202 trial
Clinical Cancer Research, Vol. 27, Núm. 18, pp. 5020-5027
2020
-
BL-8040, a CXCR4 antagonist, in combination with pembrolizumab and chemotherapy for pancreatic cancer: the COMBAT trial
Nature Medicine, Vol. 26, Núm. 6, pp. 878-885
2017
-
Pregnancy in women with hypertrophic cardiomyopathy: Data from the European Society of Cardiology initiated Registry of Pregnancy and Cardiac disease (ROPAC)
European Heart Journal, Vol. 38, Núm. 35, pp. 2683-2690
2015
-
Pregnancy in Women with a Mechanical Heart Valve
Circulation, Vol. 132, Núm. 2, pp. 132-142
2009
-
Major lipids, apolipoproteins, and risk of vascular disease
JAMA, Vol. 302, Núm. 18, pp. 1993-2000